← Leaderboards
Nureddin Ashammakhi
University Of California Los Angeles
$1,022,115
Attributed
$4,515,369
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,515,369 · 2
By mechanism
UH3$2,380,820 · 1
UG3$2,134,549 · 1
Top collaborators
- Nigel T Maidment5 shared
- Stephanie Kristin Seidlits5 shared
- Clive Niels Svendsen5 shared
- Ali Khademhosseini2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Daniel Lee Dickerson$6,564,502
- John M. Roll$12,949,169
- Robert Damoiseaux$5,020,054
- Thomas Frederick Newton$18,826,829
- Christopher J Evans$13,104,202
Others in their field
Other Emerging Leaders on “Drug Addiction”
- Eve Jelstrom · The Emmes Company, Llc$19,926,911
- Jeffrey Reich · Sparian Biosciences, Inc.$18,033,159
- Emmanuel Aja Oga · Research Triangle Institute$17,220,162
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Lashawn Glasgow · Research Triangle Institute$11,632,918
- Hongtao Yu · Morgan State University$10,225,294
Research focus
Drug AddictionDrug ScreeningDevicesDopamineDesignDrug Of AbuseAnhedoniaCravingDetectionDisinhibitionAgonistBrainAnalgesicsButyric AcidsCellsCharacteristicsAddictionChronicChronic Pain3-DimensionalComplementBiological ModelsBlood - Brain Barrier AnatomyExposure To
Grant awards (5)
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,584
UH3 · FY2024 · TR
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,584
UH3 · FY2023 · TR
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,652
UH3 · FY2022 · TR
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$531,057
UG3 · FY2021 · TR
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal and the negative affective component of pain: a therapeutic screening tool.$1,603,492
UG3 · FY2019 · TR